Deutsche Bank reiterated coverage on Westlake Chemical with a new price target
$WLKP
Major Chemicals
Industrials
Deutsche Bank reiterated coverage of Westlake Chemical with a rating of Buy and set a new price target of $31.00 from $30.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/2/2022 | $30.00 → $31.00 | Buy | Deutsche Bank |
| 7/16/2021 | $27.00 | Buy → Underperform | BofA Securities |
Declared quarterly distribution of $0.4714 per unit; 42nd consecutive quarterly distribution Westlake Chemical Partners LP (NYSE:WLKP) (the "Partnership") today reported net income attributable to the Partnership in the fourth quarter of 2024 of $15.0 million, or $0.43 per limited partner unit, which was relatively in line with fourth quarter 2023 net income of $14.3 million. Cash flows from operating activities in the fourth quarter of 2024 were $132.5 million, an increase of $24.8 million compared to fourth quarter 2023 cash flows from operating activities of $107.7 million, due to higher net income and more favorable working capital changes. For the three months ended December 31, 20
Westlake Chemical Partners (NYSE:WLKP) will release its fourth quarter and full year 2024 earnings prior to the market opening on Monday, February 24, 2025. The company will host a conference call at 1:00 p.m. Eastern Time (12:00 p.m. Central Time) on the same day to discuss the earnings release. To access the conference by phone, it is necessary to pre-register at https://register.vevent.com/register/BI294ab16856704d199e4792cc3d8bb4b0. Once registered, you will receive a phone number and unique PIN number. When you dial in, you will input the PIN number to be placed into the call. The conference call and replay will be available via webcast at https://edge.media-server.com/mmc/p/s2462h
Celebrated 10th anniversary as a publicly traded master limited partnership having grown the quarterly distribution 71% since IPO Declared quarterly distribution of $0.4714 per unit; 41st consecutive quarterly distribution Westlake Chemical Partners LP (NYSE:WLKP) (the "Partnership") today reported net income attributable to the Partnership in the third quarter of 2024 of $18.1 million, or $0.51 per limited partner unit, an increase of $4.9 million compared to the third quarter 2023 net income of $13.2 million. Cash flows from operating activities in the third quarter of 2024 were $126.1 million, an increase of $25.2 million compared to third quarter 2023 cash flows from operating acti
10-K - Westlake Chemical Partners LP (0001604665) (Filer)
8-K - Westlake Chemical Partners LP (0001604665) (Filer)
10-Q - Westlake Chemical Partners LP (0001604665) (Filer)
Deutsche Bank reiterated coverage of Westlake Chemical with a rating of Buy and set a new price target of $31.00 from $30.00 previously
BofA Securities downgraded Westlake Chemical Partners from Buy to Underperform and set a new price target of $27.00
UBS downgraded Westlake Chemical from Buy to Neutral and set a new price target of $25.00 from $23.00 previously
4 - Westlake Chemical Partners LP (0001604665) (Issuer)
4 - Westlake Chemical Partners LP (0001604665) (Issuer)
4 - Westlake Chemical Partners LP (0001604665) (Issuer)
Westlake Chemical Partners LP (NYSE:WLKP) (the "Partnership") announced that it filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2024 with the Securities and Exchange Commission on March 5, 2025. A copy of this 10-K may be found on the Partnership's website, www.wlkpartners.com, by selecting the "Investor Relations" tab, then "SEC Filings." Unitholders of the Partnership may receive a hard copy of its Annual Report on Form 10-K, including complete audited financial statements, free of charge. Requests should be submitted in writing to Westlake Chemical Partners LP – 2024 Form 10-K, 2801 Post Oak Blvd., Suite 600, Houston, TX 77056. About Westlake Chemical Partne
Declared quarterly distribution of $0.4714 per unit; 42nd consecutive quarterly distribution Westlake Chemical Partners LP (NYSE:WLKP) (the "Partnership") today reported net income attributable to the Partnership in the fourth quarter of 2024 of $15.0 million, or $0.43 per limited partner unit, which was relatively in line with fourth quarter 2023 net income of $14.3 million. Cash flows from operating activities in the fourth quarter of 2024 were $132.5 million, an increase of $24.8 million compared to fourth quarter 2023 cash flows from operating activities of $107.7 million, due to higher net income and more favorable working capital changes. For the three months ended December 31, 20
Westlake Chemical Partners (NYSE:WLKP) will release its fourth quarter and full year 2024 earnings prior to the market opening on Monday, February 24, 2025. The company will host a conference call at 1:00 p.m. Eastern Time (12:00 p.m. Central Time) on the same day to discuss the earnings release. To access the conference by phone, it is necessary to pre-register at https://register.vevent.com/register/BI294ab16856704d199e4792cc3d8bb4b0. Once registered, you will receive a phone number and unique PIN number. When you dial in, you will input the PIN number to be placed into the call. The conference call and replay will be available via webcast at https://edge.media-server.com/mmc/p/s2462h
SC 13D/A - Westlake Chemical Partners LP (0001604665) (Subject)
SC 13G/A - Westlake Chemical Partners LP (0001604665) (Subject)
SC 13G/A - Westlake Chemical Partners LP (0001604665) (Subject)
4 - Westlake Chemical Partners LP (0001604665) (Issuer)
4 - Westlake Chemical Partners LP (0001604665) (Issuer)
4 - Westlake Chemical Partners LP (0001604665) (Issuer)
Westlake Chemical Partners (NYSE:WLKP) today announced that Ms. Lisa A. Friel has been appointed to the board of directors of its general partner, Westlake Chemical Partners GP LLC. She will replace Ms. Angela A. Minas, who previously informed the company that she would resign from the board effective upon the appointment of her successor. Ms. Friel was the Managing Partner of Ernst & Young LLP's San Antonio, Texas office from July 2012 until her retirement in September 2020. Ms. Friel began her career with Ernst & Young LLP in 1988. She is currently the Chair of the Board of Directors for the United Way of San Antonio. Ms. Friel holds a bachelor's of science degree in Accounting and Busi
Retirement of Dr Sarah Ryan and Dr Christopher Haynes from the Woodside BoardPERTH, AUSTRALIA / ACCESSWIRE / March 8, 2023 / The Board of Woodside announces the retirement of Dr Sarah Ryan and Dr Christopher Haynes as Directors of Woodside. Dr Ryan and Dr Haynes will be standing down from their respective offices with effect from the conclusion of Woodside's 2023 Annual General Meeting, scheduled to be held on 28 April 2023 (2023 AGM).Dr Haynes has served on Woodside's Board since 2011 and is a member of the Audit & Risk Committee, the Sustainability Committee and the Nominations & Governance Committee.Dr Ryan joined the Woodside Board in December 2012 and serves on the Audit & Risk Committe
Crestwood Equity Partners LP (NYSE:CEQP) ("Crestwood") announced today that Angela A. Minas and Clay C. Williams have been appointed to serve on the Board of Directors of its general partner effective January 1, 2022. "I am pleased to welcome Angela and Clay to the Crestwood Board of Directors. Both of these highly regarded individuals bring a wealth of U.S. and global industry experience and perspective to our boardroom that will greatly benefit Crestwood as we navigate the dynamic energy industry and take advantage of opportunities to continue building a leading midstream infrastructure company," said Robert G. Phillips, Chairman, President and Chief Executive Officer of Crestwood's gene